NO20090057L - Regulatoriske nukleinsyre elementer - Google Patents
Regulatoriske nukleinsyre elementerInfo
- Publication number
- NO20090057L NO20090057L NO20090057A NO20090057A NO20090057L NO 20090057 L NO20090057 L NO 20090057L NO 20090057 A NO20090057 A NO 20090057A NO 20090057 A NO20090057 A NO 20090057A NO 20090057 L NO20090057 L NO 20090057L
- Authority
- NO
- Norway
- Prior art keywords
- elements
- expression
- sequence
- gene
- well
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06117862 | 2006-07-26 | ||
PCT/EP2007/055954 WO2008012142A1 (fr) | 2006-07-26 | 2007-06-15 | Éléments régulateurs d'acide nucléique |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20090057L true NO20090057L (no) | 2009-02-16 |
Family
ID=37441548
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20090057A NO20090057L (no) | 2006-07-26 | 2009-01-06 | Regulatoriske nukleinsyre elementer |
Country Status (23)
Country | Link |
---|---|
US (3) | US20080124760A1 (fr) |
EP (1) | EP2049671B1 (fr) |
JP (1) | JP5270544B2 (fr) |
KR (1) | KR101485853B1 (fr) |
CN (1) | CN101517085B (fr) |
AR (1) | AR061472A1 (fr) |
AU (1) | AU2007278368B2 (fr) |
BR (1) | BRPI0714594A2 (fr) |
CA (1) | CA2658595C (fr) |
CY (1) | CY1113711T1 (fr) |
DK (1) | DK2049671T3 (fr) |
EA (1) | EA016880B1 (fr) |
ES (1) | ES2401654T3 (fr) |
HK (1) | HK1134107A1 (fr) |
IL (1) | IL196676A0 (fr) |
MX (1) | MX2009000781A (fr) |
NO (1) | NO20090057L (fr) |
NZ (1) | NZ575115A (fr) |
PL (1) | PL2049671T3 (fr) |
PT (1) | PT2049671E (fr) |
SI (1) | SI2049671T1 (fr) |
TW (1) | TW200815591A (fr) |
WO (1) | WO2008012142A1 (fr) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120258496A1 (en) | 2010-09-27 | 2012-10-11 | Boehringer Ingelheim International Gmbh | Production of low fucose antibodies in h4-ii-e rat cells |
DK2697375T3 (en) | 2011-04-13 | 2018-01-15 | Nat Res Council Canada | EXPRESSION SYSTEM WITH A SAR (SCAFFOLD ATTACHMENT REGION) ELEMENT OF INTERFERON 2 |
SG11201401857WA (en) | 2011-10-28 | 2014-09-26 | Neotope Biosciences Ltd | Humanized antibodies that recognize alpha-synuclein |
UA115439C2 (uk) | 2012-01-27 | 2017-11-10 | Протена Біосаєнсиз Лімітед | Гуманізоване антитіло, яке розпізнає альфа-синуклеїн |
UA118441C2 (uk) | 2012-10-08 | 2019-01-25 | Протена Біосаєнсиз Лімітед | Антитіло, що розпізнає альфа-синуклеїн |
CA2902026C (fr) | 2013-03-13 | 2023-08-29 | Prothena Biosciences Limited | Immunotherapie contre tau |
US10513555B2 (en) | 2013-07-04 | 2019-12-24 | Prothena Biosciences Limited | Antibody formulations and methods |
US9951131B2 (en) | 2013-07-12 | 2018-04-24 | Prothena Biosciences Limited | Antibodies that recognize IAPP |
US9850302B2 (en) | 2013-07-12 | 2017-12-26 | Prothena Biosciences Limited | Antibodies that recognize IAPP |
US11191832B2 (en) | 2013-11-19 | 2021-12-07 | Prothena Biosciences Limited | Monitoring immunotherapy of Lewy body disease from constipation symptoms |
WO2015136471A1 (fr) | 2014-03-12 | 2015-09-17 | Prothena Biosciences Limited | Anticorps anti-laminine 4 spécifiques de lg1-3 |
TW201623331A (zh) | 2014-03-12 | 2016-07-01 | 普羅帝納生物科學公司 | 抗黑色素瘤細胞黏著分子(mcam)抗體類及使用彼等之相關方法 |
US10059761B2 (en) | 2014-03-12 | 2018-08-28 | Prothena Biosciences Limited | Anti-Laminin4 antibodies specific for LG4-5 |
PT3116911T (pt) | 2014-03-12 | 2019-09-04 | Prothena Biosciences Ltd | Anticorpos anti-mcam e métodos de utilização associados |
EP3129051A1 (fr) | 2014-04-08 | 2017-02-15 | Prothena Biosciences Limited | Navettes de la barrière hémato-encéphalique contenant des anticorps reconnaissant l'alpha-synucléine |
TWI718122B (zh) | 2015-01-28 | 2021-02-11 | 愛爾蘭商普羅佘納生物科技有限公司 | 抗甲狀腺素運送蛋白抗體 |
TWI769570B (zh) | 2015-01-28 | 2022-07-01 | 愛爾蘭商普羅佘納生物科技有限公司 | 抗甲狀腺素運送蛋白抗體 |
TWI781507B (zh) | 2015-01-28 | 2022-10-21 | 愛爾蘭商普羅佘納生物科技有限公司 | 抗甲狀腺素運送蛋白抗體 |
JP6871174B2 (ja) * | 2015-02-02 | 2021-05-12 | メイラグティーエックス ユーケー アイアイ リミティド | 選択的スプライシングのアプタマー媒介性調節による遺伝子発現の調節 |
WO2017046774A2 (fr) | 2015-09-16 | 2017-03-23 | Prothena Biosciences Limited | Utilisation d'anticorps anti-mcam pour le traitement ou la prophylaxie de l'artérite à cellules géantes, la pseudo-polyarthrite rhizomélique ou l'artérite de takayasu |
WO2017046776A2 (fr) | 2015-09-16 | 2017-03-23 | Prothena Biosciences Limited | Utilisation d'anticorps anti-mcam pour le traitement ou la prophylaxie de l'artérite à cellules géantes, la pseudo-polyarthrite rhizomélique ou l'artérite de takayasu |
WO2017149513A1 (fr) | 2016-03-03 | 2017-09-08 | Prothena Biosciences Limited | Anticorps anti-mcam et méthodes d'utilisation associées |
WO2017153955A1 (fr) | 2016-03-09 | 2017-09-14 | Prothena Biosciences Limited | Utilisation d'anticorps anti-mcam pour le traitement ou la prophylaxie de maladies pulmonaires granulomateuses |
WO2017153953A1 (fr) | 2016-03-09 | 2017-09-14 | Prothena Biosciences Limited | Utilisation d'anticorps anti-mcam pour le traitement ou la prophylaxie de maladies pulmonaires granulomateuses |
CN109219615B (zh) | 2016-05-02 | 2022-12-09 | 普罗塞纳生物科学有限公司 | 识别tau的抗体 |
HUE060258T2 (hu) | 2016-05-02 | 2023-02-28 | Prothena Biosciences Ltd | Tau immunterápia |
US10906964B2 (en) | 2016-05-02 | 2021-02-02 | Prothena Biosciences Limited | Antibodies recognizing tau |
WO2017208210A1 (fr) | 2016-06-03 | 2017-12-07 | Prothena Biosciences Limited | Anticorps anti-mcam et methodes d'utilisation associées |
WO2018007924A2 (fr) | 2016-07-02 | 2018-01-11 | Prothena Biosciences Limited | Anticorps anti-transthyrétine |
WO2018007923A2 (fr) | 2016-07-02 | 2018-01-11 | Prothena Biosciences Limited | Anticorps anti-transthyrétine |
WO2018007922A2 (fr) | 2016-07-02 | 2018-01-11 | Prothena Biosciences Limited | Anticorps anti-transthyrétine |
CU24636B1 (es) | 2017-05-02 | 2022-12-12 | Prothena Biosciences Ltd | Anticuerpos que reconocen tau en los residuos 257-271 o 320-334 de la seq id no: 1 |
WO2019064053A1 (fr) | 2017-09-28 | 2019-04-04 | Prothena Biosciences Limited | Régimes posologiques destinés au traitement de synucléinopathies |
WO2020034097A1 (fr) * | 2018-08-14 | 2020-02-20 | Wuxi Biologics (Shanghai) Co., Ltd. | Élément régulateur transcriptionnel et son utilisation dans l'amélioration de l'expression de protéine exogène |
CA3117816A1 (fr) | 2018-11-26 | 2020-06-04 | Forty Seven, Inc. | Anticorps humanises diriges contre c-kit |
JP2022524588A (ja) | 2019-03-03 | 2022-05-09 | プロセナ バイオサイエンシーズ リミテッド | タウ認識抗体 |
JP7412860B2 (ja) | 2020-10-16 | 2024-01-15 | 株式会社奥村組 | 泥水式シールド掘進機および泥水式シールド掘進機における圧縮空気の圧力調整方法 |
CA3217224A1 (fr) * | 2021-04-21 | 2022-10-27 | Janssen Biotech, Inc. | Substances et methodes associees a des phosphotransferases ameliorees |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3584341D1 (de) | 1984-08-24 | 1991-11-14 | Upjohn Co | Rekombinante dna-verbindungen und expression von polypeptiden wie tpa. |
DK0393438T3 (da) | 1989-04-21 | 2005-05-30 | Amgen Inc | TNF-receptor, TNF-bindende proteiner og DNAér, der koder herfor |
AU650085B2 (en) | 1990-11-13 | 1994-06-09 | Immunex Corporation | Bifunctional selectable fusion genes |
US5786166A (en) | 1991-10-25 | 1998-07-28 | University Of Tennessee Research Corporation | Methods for determining effects of a compound on the activity of bacterial periplasmic oxidoreductase enzymes |
DE4228458A1 (de) | 1992-08-27 | 1994-06-01 | Beiersdorf Ag | Multicistronische Expressionseinheiten und deren Verwendung |
EP0804590A1 (fr) | 1993-05-21 | 1997-11-05 | Targeted Genetics Corporation | Genes de fusion selectables et bifonctionnels se basant sur le gene de cytosine-deaminase (cd) |
DE19539493A1 (de) * | 1995-10-24 | 1997-04-30 | Thomae Gmbh Dr K | Starker homologer Promotor aus Hamster |
DK0873405T3 (da) * | 1996-01-11 | 2005-01-17 | Immunex Corp | Ekspressionsforøgende sekvenselementer (EASE) til eukaryote ekspressionssystemer |
WO2000034326A1 (fr) | 1998-12-11 | 2000-06-15 | Clontech Laboratories, Inc. | Proteines fluorescentes non bioluminescentes d'especes anthozoaires, genes codant ces proteines et leurs utilisations |
WO2000034325A1 (fr) | 1998-12-11 | 2000-06-15 | Clontech Laboratories, Inc. | Proteines fluorescentes d'especes anthozoaires non bioluminescentes, genes codant ces proteines et utilisation |
JP4618891B2 (ja) | 1998-12-11 | 2011-01-26 | クロンテック・ラボラトリーズ・インコーポレーテッド | Anthozoa綱の非生物発光性種由来の蛍光タンパク質、そのようなタンパク質をコードする遺伝子、およびそれらの使用 |
AUPP967999A0 (en) * | 1999-04-09 | 1999-05-06 | North Western Health Care Network | Viral variants |
DK1196566T3 (da) | 1999-07-12 | 2006-06-06 | Genentech Inc | Ekspressionsvektorer og -metoder |
AU783767B2 (en) | 1999-10-14 | 2005-12-01 | Takara Bio Usa, Inc. | Anthozoa derived chromophores/fluorophores and methods for using the same |
CA2443275C (fr) | 2001-04-05 | 2013-02-05 | Ml Laboratories Plc | Expression genique amelioree |
ATE474053T1 (de) | 2001-07-04 | 2010-07-15 | Chromagenics Bv | Dns-sequenzen mit anti-repressor-aktivität |
KR101149777B1 (ko) | 2002-11-29 | 2012-06-11 | 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 | 신규한 네오마이신 포스포트랜스퍼라제 유전자 및 고생산성 재조합 세포의 선별 방법 |
US7344886B2 (en) | 2002-11-29 | 2008-03-18 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene product |
DE10256083A1 (de) | 2002-11-29 | 2004-08-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Expressionsvektor, Verfahren zur Herstellung von heterologen Genprodukten und Selektionsverfahren für hochproduzierende rekombinante Zellen |
US7384744B2 (en) * | 2002-11-29 | 2008-06-10 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products |
-
2007
- 2007-06-13 US US11/762,240 patent/US20080124760A1/en not_active Abandoned
- 2007-06-14 TW TW096121483A patent/TW200815591A/zh unknown
- 2007-06-15 MX MX2009000781A patent/MX2009000781A/es active IP Right Grant
- 2007-06-15 EA EA200900212A patent/EA016880B1/ru not_active IP Right Cessation
- 2007-06-15 DK DK07730192.7T patent/DK2049671T3/da active
- 2007-06-15 CA CA2658595A patent/CA2658595C/fr active Active
- 2007-06-15 PT PT77301927T patent/PT2049671E/pt unknown
- 2007-06-15 CN CN2007800359296A patent/CN101517085B/zh active Active
- 2007-06-15 JP JP2009521178A patent/JP5270544B2/ja active Active
- 2007-06-15 SI SI200731174T patent/SI2049671T1/sl unknown
- 2007-06-15 NZ NZ575115A patent/NZ575115A/en not_active IP Right Cessation
- 2007-06-15 ES ES07730192T patent/ES2401654T3/es active Active
- 2007-06-15 EP EP07730192A patent/EP2049671B1/fr active Active
- 2007-06-15 KR KR1020097004079A patent/KR101485853B1/ko active IP Right Grant
- 2007-06-15 AU AU2007278368A patent/AU2007278368B2/en active Active
- 2007-06-15 AR ARP070102632A patent/AR061472A1/es active Pending
- 2007-06-15 PL PL07730192T patent/PL2049671T3/pl unknown
- 2007-06-15 WO PCT/EP2007/055954 patent/WO2008012142A1/fr active Application Filing
- 2007-06-15 BR BRPI0714594-2A patent/BRPI0714594A2/pt not_active IP Right Cessation
-
2009
- 2009-01-06 NO NO20090057A patent/NO20090057L/no not_active Application Discontinuation
- 2009-01-22 IL IL196676A patent/IL196676A0/en unknown
-
2010
- 2010-01-28 HK HK10100907.0A patent/HK1134107A1/xx not_active IP Right Cessation
- 2010-07-23 US US12/842,468 patent/US9045776B2/en active Active
-
2013
- 2013-02-21 CY CY20131100160T patent/CY1113711T1/el unknown
-
2015
- 2015-04-29 US US14/699,182 patent/US9708626B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2049671B1 (fr) | 2012-12-19 |
US20150337333A1 (en) | 2015-11-26 |
JP2009544293A (ja) | 2009-12-17 |
MX2009000781A (es) | 2009-01-29 |
ES2401654T3 (es) | 2013-04-23 |
SI2049671T1 (sl) | 2013-04-30 |
JP5270544B2 (ja) | 2013-08-21 |
CA2658595C (fr) | 2016-05-31 |
US20080124760A1 (en) | 2008-05-29 |
PT2049671E (pt) | 2013-01-24 |
EP2049671A1 (fr) | 2009-04-22 |
BRPI0714594A2 (pt) | 2013-02-19 |
EA200900212A1 (ru) | 2009-10-30 |
AU2007278368B2 (en) | 2013-12-19 |
DK2049671T3 (da) | 2013-04-08 |
PL2049671T3 (pl) | 2013-05-31 |
HK1134107A1 (en) | 2010-04-16 |
EA016880B1 (ru) | 2012-08-30 |
KR20090046887A (ko) | 2009-05-11 |
IL196676A0 (en) | 2011-08-01 |
WO2008012142A1 (fr) | 2008-01-31 |
NZ575115A (en) | 2011-10-28 |
AU2007278368A1 (en) | 2008-01-31 |
KR101485853B1 (ko) | 2015-01-23 |
US9045776B2 (en) | 2015-06-02 |
AR061472A1 (es) | 2008-08-27 |
US20100311121A1 (en) | 2010-12-09 |
CA2658595A1 (fr) | 2008-01-31 |
CY1113711T1 (el) | 2016-06-22 |
CN101517085A (zh) | 2009-08-26 |
CN101517085B (zh) | 2013-08-07 |
TW200815591A (en) | 2008-04-01 |
US9708626B2 (en) | 2017-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20090057L (no) | Regulatoriske nukleinsyre elementer | |
Gavazzi et al. | A functional sequence-specific interaction between influenza A virus genomic RNA segments | |
Fechter et al. | Recognition of mRNA cap structures by viral and cellular proteins | |
Panwar et al. | Host-induced gene silencing of wheat leaf rust fungus Puccinia triticina pathogenicity genes mediated by the Barley stripe mosaic virus | |
Scheller et al. | Translation and replication of hepatitis C virus genomic RNA depends on ancient cellular proteins that control mRNA fates | |
Gultyaev et al. | Influenza virus RNA structure: unique and common features | |
MX2009003090A (es) | Genes novedosos relacionados con ciclasa de glutaminilo. | |
WO2007002008A3 (fr) | Procedes et compositions permettant d'exprimer un virus a arn sens negatif dans des cellules canines | |
Nishimori et al. | Sulfonamide inhibition studies of two β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila | |
ATE440950T1 (de) | Konstrukte und verfahren zur regulation der genexpression | |
BR0307253A (pt) | Construtos de dna, sistema de expressão, métodos de supressão da expressão de um gene alvo numa célula, célula de planta transformada, planta transgênica e kit de supressão de expressão genética | |
AU2007240448A8 (en) | Methods and compositions for expressing negative-sense viral RNA in canine cells | |
Huang et al. | The Mediator kinase module serves as a positive regulator of salicylic acid accumulation and systemic acquired resistance | |
PE20120115A1 (es) | Composiciones y metodos para inhibir la expresion de genes del factor vii | |
Wang et al. | Polymorphisms in cis‐elements confer SAUR26 gene expression difference for thermo‐response natural variation in Arabidopsis | |
Widjaja et al. | Competition between influenza A virus genome segments | |
EP2557166A3 (fr) | Promoteurs préférentiels du cambium/xylème et utilisations associées | |
Procházková Schrumpfová et al. | Role of HMGB proteins in chromatin dynamics and telomere maintenance in Arabidopsis thaliana | |
BRPI0820004A8 (pt) | Molécula de ácido nucléico isolada, cassete de expressão, vetor, método para obter uma célula vegetal, método para obter uma planta, método para expressar um polinucleotídeo em uma planta ou uma célula vegetal, método para expressar um polinucleotídeo preferencialmente em tecidos reprodutivos de uma planta | |
AR068529A1 (es) | Uso de clec1b (lecitina tipo c de familia de dominio i, miembro b) | |
Dalakouras et al. | A chimeric satellite transgene sequence is inefficiently targeted by viroid-induced DNA methylation in tobacco | |
CA3058540A1 (fr) | Modification d'acide nucleique et procede d'identification | |
Rodriguez et al. | Mutations of the segment-specific nucleotides at the 3’end of influenza virus NS segment control viral replication | |
Zhang et al. | Fundamental contribution and host range determination of ANP32 protein family in influenza A virus polymerase activity | |
Lee et al. | Construction and characterization of an aureusvirus defective RNA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |